Literature DB >> 7087893

Nasopharyngeal carcinoma in childhood.

F Lombardi, M Gasparini, C Gianni, M De Marie, R Molinari, S Pilotti.   

Abstract

We have retrospectively evaluated a series of 27 consecutive children observed from 1965 to 1980 with nasopharyngeal carcinoma (NPC). Histological diagnosis in each patient was undifferentiated carcinoma of nasopharyngeal type (UCNT) with prominent lymphocytic infiltration. Regional node involvement was present in 26 of 27 patients and two children presented with distant metastases. Twenty evaluable children with primary nasopharyngeal tumor with or without positive cervical nodes underwent radiotherapy (RT) with uniform criteria in technique. Adjuvant cyclophosphamide (CPM) was administered to a total of 11 children. The actuarial relapse-free survival and overall survival are 40% and 55% at four years, respectively. In this series, the most important prognostic factor was represented by the extent of the tumor in the nasopharynx. Permanent control of the primary tumor was obtained in 85% of patients. CPM given after RT did not reduce the incidence of relapse. However, the fact that 45% of patients developed distant metastases as first treatment failure suggests that combined chemotherapy should be tested in the management of NPC in children, especially when primary tumor is locally advanced.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7087893     DOI: 10.1002/mpo.2950100304

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  7 in total

1.  Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

Authors:  Daniel Ka Leung Cheuk; Catherine A Billups; Michael G Martin; Cynthia R Roland; Raul C Ribeiro; Matthew J Krasin; Carlos Rodriguez-Galindo
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

Review 2.  Update in pediatric nasopharyngeal undifferentiated carcinoma.

Authors:  Line Claude; Emmanuel Jouglar; Loig Duverge; Daniel Orbach
Journal:  Br J Radiol       Date:  2019-07-31       Impact factor: 3.039

3.  Nasopharyngeal Carcinoma: A 15 Year Study with Respect to Clinicodemography and Survival Analysis.

Authors:  Shaqul Qamar Wani; Talib Khan; Saiful Yamin Wani; Liza Rafiq Mir; Mohammad Maqbool Lone; Tariq Rasool Malik; Arshad Manzoor Najmi; Fir Afroz; Mohammad Ashraf Teli; Nazir Ahmad Khan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-09-19

Review 4.  The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.

Authors:  Elham Hassen; Ghandri Nahla; Noureddine Bouaouina; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2009-05-17       Impact factor: 2.316

5.  Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients.

Authors:  Said Afqir; Nabil Ismaili; Khaoula Alaoui; Samir Ahid; Jean-Pierre Lotz; Elizabeth Horn; Touria Bouhafa; Redouane Abouqal; Hassan Errihani
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-22       Impact factor: 2.503

Review 6.  Prognostic aspects in the treatment of juvenile nasopharyngeal carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Giuseppe Magliulo; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-18       Impact factor: 2.503

Review 7.  Nasopharyngeal carcinoma.

Authors:  Bernadette Brennan
Journal:  Orphanet J Rare Dis       Date:  2006-06-26       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.